NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA)
Clinical trials for NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA) explained in plain language.
Never miss a new study
Get alerted when new NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA) trials appear
Sign up with your email to follow new studies for NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill help people with progressive speech loss?
Symptom relief Recruiting nowThis study tests an experimental drug called neflamapimod in 20 people with a rare condition that slowly destroys the ability to speak (primary progressive aphasia). The main goal is to check safety and see if the drug can improve language symptoms. Participants take the drug for…
Matched conditions: NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA)
Phase: PHASE2 • Sponsor: EIP Pharma Inc • Aim: Symptom relief
Last updated Jun 15, 2026 19:03 UTC
-
New virtual therapy aims to help dementia patients communicate better with loved ones
Symptom relief Recruiting nowThis study tests a personalized, virtual speech therapy program for people with primary progressive aphasia (a type of dementia that affects language) and their communication partners. The goal is to see if the program improves communication and quality of life. About 30 particip…
Matched conditions: NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA)
Phase: NA • Sponsor: Maya Henry • Aim: Symptom relief
Last updated Jun 10, 2026 13:26 UTC